LON:CVSG CVS Group (CVSG) Share Price, News & Analysis GBX 1,257 +24.00 (+1.95%) As of 12:01 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock About CVS Group Stock (LON:CVSG) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get CVS Group alerts:Sign Up Key Stats Today's Range 1,235▼ 1,27050-Day Range 1,114▼ 1,26952-Week Range 1,062▼ 1,648Volume201,668 shsAverage Volume973,101 shsMarket Capitalization£881.87 millionP/E Ratio18.24Dividend Yield0.69%Price TargetGBX 1,724Consensus RatingModerate Buy Company Overview CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy. The Group operates from over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business ("Animed Direct"). The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses. Read More CVS Group Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks77th Percentile Overall ScoreCVSG MarketRank™: CVS Group scored higher than 77% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.6 / 5Analyst RatingModerate Buy Consensus RatingCVS Group has received a consensus rating of Moderate Buy. The company's average rating score is 2.80, and is based on no strong buy ratings, 4 buy ratings, 1 hold rating, and no sell ratings.Upside PotentialCVS Group has a consensus price target of GBX 1,724, representing about 37.2% upside from its current price of GBX 1,257.Amount of Analyst CoverageCVS Group has only been the subject of 1 research reports in the past 90 days.Read more about CVS Group's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of CVS Group is 18.24, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.92.Price to Earnings Ratio vs. SectorThe P/E ratio of CVS Group is 18.24, which means that it is trading at a less expensive P/E ratio than the Consumer Cyclical sector average P/E ratio of about 76.63.Price to Earnings Growth RatioCVS Group has a PEG Ratio of 1.77. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioCVS Group has a P/B Ratio of 3.46. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for CVSG. Dividend0.8 / 5Dividend StrengthWeak Dividend YieldCVS Group has a dividend yield of 0.69%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthCVS Group does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of CVS Group is 12.34%. This payout ratio is at a healthy, sustainable level, below 75%.Read more about CVS Group's dividend. News and Social Media3.3 / 5News Sentiment1.29 News SentimentCVS Group has a news sentiment score of 1.29. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.49 average news sentiment score of Consumer Cyclical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for CVS Group this week, compared to 1 article on an average week. Company Ownership2.8 / 5Insider TradingAcquiring Shares Net Insider BuyingOver the last three months, insiders have purchased a net £12,534.90 in company stock, which represents 0.0014% of the company's market cap.Insider Buying vs. Insider SellingIn the past three months, CVS Group insiders have bought more of their company's stock than they have sold. Specifically, they have bought £12,534.90 in company stock and sold GBX 0 in company stock.Percentage Held by Insiders1.42% of the stock of CVS Group is held by insiders.Percentage Held by Institutions48.54% of the stock of CVS Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about CVS Group's insider trading history. Receive CVSG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CVS Group and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CVSG Stock News HeadlinesCVS Group updates total voting rights after latest share buybackMay 29, 2026 | tipranks.comScott Morrison Acquires 987 Shares of CVS Group (LON:CVSG) StockMay 29, 2026 | insidertrades.comTrump’s New Dollar revealedThe last time something like this happened was 1974 - a secret deal that quietly determined the financial fate of an entire generation. According to Porter Stansberry, founder of one of the largest independent financial research firms in the world, it is happening again. Fortune calls it 'the biggest change to the world's relationship with the dollar' in a generation. Stansberry says Trump's money reset - enacted through executive orders and a treaty signed by 13 nations in December 2025 called Pax Silica - could determine whether you are enriched or quietly impoverished by the shift already underway.June 4 at 1:00 AM | Porter & Company (Ad)Scott Morrison Purchases 987 Shares of CVS Group (LON:CVSG) StockMay 28, 2026 | americanbankingnews.comCVS Group refreshes non-executive board roles ahead of director retirementMay 26, 2026 | tipranks.comCVS Group Launches £50m Share Buyback to Streamline Capital BaseMay 26, 2026 | tipranks.comCVS Group refinances debt, launches £50m buyback and steps up Australian expansionMay 26, 2026 | tipranks.comConverium Capital Sends Letter to CVS Group Board Highlighting Company's Undervaluation and Urging £100 Million Share BuybackMay 13, 2026 | tmcnet.comSee More Headlines CVSG Stock Analysis - Frequently Asked Questions How have CVSG shares performed this year? CVS Group's stock was trading at GBX 1,284 at the beginning of 2026. Since then, CVSG shares have decreased by 1.6% and is now trading at GBX 1,263. How were CVS Group's earnings last quarter? CVS Group plc (LON:CVSG) announced its earnings results on Thursday, February, 26th. The company reported $40.20 EPS for the quarter. CVS Group had a net margin of 2.31% and a trailing twelve-month return on equity of 5.35%. Read the conference call transcript. Is CVS Group buying back stock? CVS Group's board approved a stock buyback plan on Tuesday, May 26th 2026, which allows the company to buy back 0 shares, according to EventVestor. This allows the company to buy shares of its stock through open market purchases. Shares buyback plans are usually an indication that the company's board believes its shares are undervalued. How do I buy shares of CVS Group? Shares of CVSG stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of CVS Group own? Based on aggregate information from My MarketBeat watchlists, some other companies that CVS Group investors own include Meta Platforms (META), Salesforce (CRM), NVIDIA (NVDA), Pfizer (PFE), Qualcomm (QCOM), AbbVie (ABBV) and Walt Disney (DIS). Company Calendar Last Earnings2/26/2026Today6/04/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorConsumer Cyclical Industry Personal Services Sub-IndustryN/A Current SymbolLON:CVSG CIKN/A Webwww.cvsukltd.co.uk Phone+44-1379-644288FaxN/AEmployees9,100Year FoundedN/APrice Target and Rating Average Price Target for CVS GroupGBX 1,724 High Price TargetGBX 2,000 Low Price TargetGBX 1,420 Potential Upside/Downside+37.2%Consensus RatingModerate Buy Rating Score (0-4)2.80 Research Coverage5 Analysts Profitability EPS (Trailing Twelve Months)GBX 68.90 Trailing P/E Ratio18.24 Forward P/E Ratio13.38 P/E Growth1.77Net Income£20.68 million Net Margins2.31% Pretax MarginN/A Return on Equity5.35% Return on Assets5.03% Debt Debt-to-Equity Ratio121.52 Current Ratio1.07 Quick Ratio0.90 Sales & Book Value Annual Sales£692.80 million Price / Sales1.27 Cash FlowGBX 41.44 per share Price / Cash Flow30.33 Book ValueGBX 363.16 per share Price / Book3.46Miscellaneous Outstanding Shares70,157,000Free FloatN/AMarket Cap£881.87 million OptionableNot Optionable Beta1.02 5G Stocks: The Path Forward is ProfitableClick the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report This page (LON:CVSG) was last updated on 6/4/2026 by MarketBeat.com Staff. From Our PartnersTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredHow to claim a stake in SpaceX before the June 12 IPOSpaceX is expected to go public on June 12 - and for the first time, everyday investors may have a way in befo...Brownstone Research | SponsoredYour book attachedYour Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...Profits Run | SponsoredTrump’s secret China dealTrump just returned from Beijing with the most powerful business delegation in American history - Elon Musk, J...Porter & Company | SponsoredJune 4: The day smart money moves (not June 12)Everyone is watching June 12 - the SpaceX listing date. The real deadline is June 4, when Goldman Sachs, Morga...Behind the Markets | SponsoredGiving “2022 pre-ChatGPT” vibes (but 10x bigger)When ChatGPT launched in 2022, Nvidia surged 1,800% over three years. Now, Nvidia's CEO suggests July 22nd cou...StocksToTrade | SponsoredFree! Expert Tom Busby’s “Little Black Book”Wall Street veteran Tom Busby is giving away his 'Little Black Book' - a free guide built on 40 years of profe...DTI Trader | SponsoredAI breakthrough hidden inside SpaceX exposed on June 11On June 11, SpaceX is hosting a major investor event - and growth investor Louis Navellier believes Elon Musk ...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CVS Group plc Please log in to your account or sign up in order to add this asset to your watchlist. Share CVS Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.